Robin A Patrawala, MD
Cardiac Electrophysiology · East Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 5 carriers
- Offices
- 8
Offices
8 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Adventist Health Sonora · Mills-Peninsula Medical Center · Sequoia Hospital. That is not proof they admit you there this week.
Plans that list them
18 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Patrawala’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A54594 · Current
Licensed to practise in California · since 1995 · expires 2026-11-30 · University of California, Los Angeles School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health SonoraSonora, CAAcute Care Hospital · Voluntary non-profit - Church · No emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 64% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Postoperative wound dehiscence rate: 3.5 (2.04 to 4.96) · 288 cases, Jul 2022 – Jun 2024Worse than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 1.3 (1 to 1.6) · 1,004 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.185, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Sonora
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 1 better, 7 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative wound dehiscence rateComplications and deaths | 3.5 (2.04 to 4.96) · 288 cases | Worse | Jul 2022 – Jun 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (1 to 1.6) · 1,004 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.185 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.15 (0.14 to 2.16) · 582 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.5 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 182.91 (123.44 to 242.37) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 118 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9 · 125 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.7 · 236 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15 · 433 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12 · 72 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 1,364 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.39) · 3,671 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.07 to 0.48) · 3,602 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.24 to 5.59) · 803 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.24) · 310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.59 (0.98 to 4.2) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.97 (0 to 16.16) · 306 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.72 (1.85 to 9.58) · 277 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 1.06) · 2,750 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.614 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.6 · 105 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 209 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 12.6 · 119 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -23.8 · 255 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -13.4 · 455 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 381 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6 (4.3 to 8.1) · 328 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.7 (9.1 to 14.7) · 328 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 106 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.3) · 1,835 cases | No different | Jan 2022 – Dec 2024 |
What patients said (326 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$350,903
Medicare paid this office $350,903 for 1,104 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 348 | $82,107 | $160 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 131 | $39,924 | $289 |
| New patient visit (60+ min) | 189 | $36,226 | $192 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 180 | $35,800 | $185 |
| Return visit (30+ min) | 230 | $27,947 | $114 |
See all 26 services
| Long return visit (40+ min) | 348 | $82,107 | $160 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 131 | $39,924 | $289 |
| New patient visit (60+ min) | 189 | $36,226 | $192 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 180 | $35,800 | $185 |
| Return visit (30+ min) | 230 | $27,947 | $114 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 128 | $21,856 | $109 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 119 | $18,357 | $107 |
| Long return visit (40+ min) | 107 | $13,924 | $128 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 476 | $10,062 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 450 | $8,999 | $13 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 30 | $6,553 | $218 |
| Repair of left upper heart chamber with implant with review by radiologist | 13 | $5,241 | $403 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $4,007 | $103 |
| Programming of dual lead pacemaker system | 38 | $4,002 | $77 |
| Programming of heart rhythm stimulation after drug infusion | 142 | $3,362 | $22 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 139 | $3,337 | $22 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 12 | $3,167 | $244 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 43 | $2,451 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 38 | $2,333 | $23 |
| External shock to heart to regulate heart beat | 22 | $2,326 | $97 |
| 3d radiographic procedure | 73 | $1,997 | $26 |
| Heart rhythm recording of continous external ekg over 8-15 days | 136 | $1,817 | $12 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,799 | $150 |
| Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | 12 | $1,044 | $80 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 31 | $694 | $20 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 31 | $439 | $13 |
Procedures Medicare counted
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
1,104 Original Medicare patients in 2024. Average age 77 · Women 51% · Also on Medicaid 4% · Health risk score 1.15. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 1.8.
Conditions among them: High blood pressure 75% · Atrial fibrillation 67% · Coronary heart disease 37% · Heart failure 25% · Diabetes 21% · Chronic kidney disease 20% · Cancer 16% · Depression 13% · COPD 10% · Stroke 8% · Dementia 6%.
The office billed $1,618,789, Medicare allowed $460,945 and paid $350,903; for 4,295 services of 53 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,104 | 4,295 | 77 | 1.15 | $1,618,789 | $350,903 |
| 2023 | 1,016 | 3,665 | 77 | 1.13 | $1,473,220 | $327,127 |
| 2022 | 939 | 3,461 | 77 | 1.17 | $1,349,862 | $327,583 |
| 2021 | 807 | 3,794 | 77 | 1.22 | $1,485,389 | $396,554 |
| 2020 | 497 | 3,281 | 77 | 1.26 | $1,251,158 | $328,513 |
| 2019 | 568 | 3,812 | 77 | 1.21 | $1,319,091 | $316,940 |
| 2018 | 594 | 3,483 | 76 | 1.31 | $1,397,438 | $344,950 |
| 2017 | 547 | 3,256 | 76 | 1.30 | $1,462,540 | $376,731 |
| 2016 | 559 | 3,294 | 76 | 1.29 | $1,550,393 | $388,906 |
| 2015 | 551 | 2,960 | 76 | 1.44 | $1,456,272 | $391,158 |
| 2014 | 541 | 3,137 | 75 | 1.34 | $2,261,763 | $483,739 |
| 2013 | 514 | 3,302 | 75 | 1.41 | $2,356,076 | $488,183 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 24 services
| Long return visit (40+ min) | 313 | $68,517 | $153 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 136 | $48,259 | $347 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 164 | $36,127 | $194 |
| New patient visit (60+ min) | 163 | $31,856 | $195 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 129 | $26,827 | $114 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 122 | $23,907 | $115 |
| Return visit (30+ min) | 188 | $21,979 | $108 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 440 | $9,740 | $13 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 42 | $9,031 | $205 |
| Repair of left upper heart chamber with implant with review by radiologist | 15 | $5,968 | $398 |
| Programming of heart rhythm stimulation after drug infusion | 135 | $4,628 | $34 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $4,028 | $101 |
| Programming of dual lead pacemaker system | 41 | $3,984 | $75 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 121 | $2,715 | $22 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 108 | $2,630 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 39 | $2,481 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 34 | $2,386 | $25 |
| External shock to heart to regulate heart beat | 21 | $2,080 | $99 |
| 3d radiographic procedure | 61 | $1,563 | $25 |
| Heart rhythm recording of continous external ekg over 8-15 days | 108 | $1,434 | $12 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 120 | $1,117 | $9 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 42 | $949 | $21 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 41 | $571 | $13 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 22 | $421 | $17 |
2022: 26 services
| Long return visit (40+ min) | 284 | $66,508 | $159 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 126 | $58,420 | $449 |
| New patient visit (60+ min) | 159 | $31,086 | $196 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 120 | $29,920 | $131 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 112 | $28,240 | $130 |
| Return visit (30+ min) | 192 | $23,142 | $109 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 87 | $17,543 | $197 |
| Repair of left upper heart chamber with implant with review by radiologist | 33 | $14,978 | $454 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 346 | $7,129 | $13 |
| Programming of heart rhythm stimulation after drug infusion | 121 | $5,716 | $46 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $4,628 | $91 |
| Programming of dual lead pacemaker system | 32 | $3,511 | $82 |
| External shock to heart to regulate heart beat | 32 | $3,176 | $99 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $2,909 | $242 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 109 | $2,703 | $24 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 112 | $2,627 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 41 | $2,295 | $22 |
| Telephone medical discussion with physician, 21-30 minutes | 22 | $2,270 | $95 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 33 | $1,923 | $23 |
| Heart rhythm recording of continous external ekg over 8-15 days | 109 | $1,679 | $15 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 112 | $1,052 | $9 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 11 | $1,020 | $23 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 38 | $843 | $22 |
| 3d radiographic procedure | 35 | $837 | $23 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 38 | $579 | $15 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 24 | $535 | $22 |
2021: 31 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 121 | $67,169 | $546 |
| Long return visit (40+ min) | 256 | $64,090 | $157 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 108 | $39,706 | $222 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 99 | $30,544 | $218 |
| Return visit (30+ min) | 228 | $30,128 | $115 |
| New patient visit (60+ min) | 128 | $25,876 | $202 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 138 | $19,530 | $140 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 82 | $17,635 | $203 |
| Repair of left upper heart chamber with implant with review by radiologist | 35 | $15,334 | $438 |
| Programming of heart rhythm stimulation after drug infusion | 137 | $9,615 | $69 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 120 | $7,666 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 249 | $5,421 | $14 |
| Telephone medical discussion with physician, 21-30 minutes | 50 | $5,382 | $94 |
| External shock to heart to regulate heart beat | 36 | $4,126 | $101 |
| Programming of dual lead pacemaker system | 33 | $3,703 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $3,642 | $93 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 15 | $3,597 | $240 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 54 | $3,368 | $25 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 107 | $2,773 | $24 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 13 | $2,755 | $212 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 42 | $2,689 | $25 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 111 | $2,580 | $23 |
| Heart rhythm recording of continous external ekg over 8-15 days | 106 | $1,780 | $15 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 17 | $1,606 | $25 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 111 | $1,075 | $10 |
| 3d radiographic procedure | 35 | $868 | $23 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $855 | $33 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 26 | $651 | $22 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 24 | $565 | $22 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 15 | $508 | $34 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 24 | $402 | $15 |
2020: 31 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 111 | $75,282 | $643 |
| Long return visit (40+ min) | 218 | $41,950 | $137 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 88 | $31,440 | $260 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 83 | $21,810 | $242 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 119 | $21,007 | $167 |
| Return visit (30+ min) | 186 | $18,738 | $89 |
| New patient visit (60+ min) | 90 | $16,623 | $185 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 65 | $13,842 | $204 |
| Programming of heart rhythm stimulation after drug infusion | 116 | $11,145 | $90 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 108 | $8,465 | $73 |
| Telephone medical discussion with physician, 21-30 minutes | 56 | $6,648 | $102 |
| External shock to heart to regulate heart beat | 46 | $5,248 | $103 |
| Repair of left upper heart chamber with implant with review by radiologist | 11 | $4,907 | $446 |
| External ekg recording for more than 48 hours up to 21 days | 130 | $4,116 | $27 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 130 | $3,636 | $24 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $3,446 | $96 |
| Anticoagulant management of patient taking warfarin | 11 | $3,240 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 171 | $2,974 | $15 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 45 | $2,663 | $24 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 94 | $2,335 | $23 |
| Programming of dual lead pacemaker system | 23 | $2,115 | $66 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 35 | $2,005 | $24 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 17 | $1,879 | $24 |
| Long return visit (40+ min) | 11 | $1,328 | $102 |
| Return visit (30+ min) | 16 | $1,297 | $72 |
| Ultrasonic guidance for blood vessel access | 45 | $1,210 | $13 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 13 | $1,010 | $20 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 93 | $925 | $9 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 11 | $910 | $31 |
| 3d radiographic procedure | 20 | $461 | $23 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 50 | $395 | $6 |
2019: 36 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 132 | $59,530 | $435 |
| Long return visit (40+ min) | 178 | $28,080 | $117 |
| Return visit (30+ min) | 237 | $25,331 | $92 |
| New patient visit (60+ min) | 122 | $21,691 | $178 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 96 | $20,103 | $205 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 123 | $16,424 | $129 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 74 | $16,398 | $205 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 72 | $16,380 | $218 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 419 | $9,503 | $15 |
| Programming of heart rhythm stimulation after drug infusion | 111 | $8,485 | $74 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 122 | $6,861 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $6,273 | $94 |
| Repair of left upper heart chamber with implant with review by radiologist | 13 | $5,674 | $436 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 20 | $4,636 | $232 |
| Programming of dual lead pacemaker system | 50 | $4,592 | $61 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 12 | $4,490 | $374 |
| External shock to heart to regulate heart beat | 37 | $4,256 | $101 |
| Anticoagulant management of patient taking warfarin | 15 | $4,234 | $10 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,829 | $182 |
| External ekg recording for more than 48 hours up to 21 days | 106 | $2,991 | $26 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 106 | $2,744 | $24 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 73 | $1,902 | $23 |
| Long return visit (40+ min) | 13 | $1,404 | $100 |
| 3d radiographic procedure | 60 | $1,393 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 26 | $1,360 | $24 |
| Short return visit (20+ min) | 15 | $1,111 | $69 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $1,038 | $55 |
| Ultrasonic guidance for blood vessel access | 40 | $1,036 | $13 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 19 | $933 | $25 |
| Return visit (30+ min) | 12 | $786 | $66 |
| Short return visit (20+ min) | 17 | $784 | $46 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 72 | $753 | $10 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 85 | $736 | $6 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 22 | $522 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $505 | $27 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 11 | $496 | $12 |
2018: 34 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 134 | $92,847 | $668 |
| Return visit (30+ min) | 269 | $27,775 | $85 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 121 | $27,576 | $219 |
| Long return visit (40+ min) | 141 | $22,076 | $133 |
| New patient visit (60+ min) | 93 | $16,864 | $181 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 45 | $16,530 | $359 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 64 | $13,226 | $200 |
| Programming of heart rhythm stimulation after drug infusion | 89 | $12,497 | $134 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 116 | $10,130 | $84 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 403 | $8,437 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $8,060 | $93 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 21 | $7,700 | $367 |
| External shock to heart to regulate heart beat | 61 | $6,483 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,401 | $180 |
| Repair of left upper heart chamber with implant with review by radiologist | 12 | $5,181 | $432 |
| Anticoagulant management of patient taking warfarin | 14 | $4,778 | $11 |
| Programming of dual lead pacemaker system | 39 | $3,152 | $50 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 11 | $2,531 | $230 |
| External ekg recording for more than 48 hours up to 21 days | 82 | $2,215 | $25 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 81 | $2,086 | $23 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 75 | $1,859 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 30 | $1,543 | $25 |
| Return visit (30+ min) | 18 | $1,258 | $70 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 22 | $982 | $25 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $970 | $65 |
| 3d radiographic procedure | 36 | $842 | $23 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 91 | $831 | $6 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 73 | $738 | $9 |
| Ultrasound of heart blood flow, valves and chambers | 11 | $601 | $55 |
| Short return visit (20+ min) | 11 | $481 | $44 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 12 | $433 | $12 |
| Ultrasonic guidance for blood vessel access | 17 | $432 | $13 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 18 | $418 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $322 | $27 |
2017: 32 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 156 | $103,193 | $645 |
| Return visit (30+ min) | 370 | $49,534 | $89 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 155 | $38,504 | $242 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 61 | $22,136 | $357 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 76 | $18,154 | $230 |
| New patient visit (60+ min) | 89 | $16,432 | $185 |
| Programming of heart rhythm stimulation after drug infusion | 98 | $13,657 | $138 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 133 | $11,172 | $82 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 27 | $9,630 | $357 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 392 | $9,222 | $16 |
| External shock to heart to regulate heart beat | 56 | $6,013 | $100 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 19 | $5,182 | $273 |
| Programming of dual lead pacemaker system | 46 | $3,940 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $3,720 | $93 |
| 3d radiographic procedure with computerized image postprocessing | 42 | $2,927 | $68 |
| External ekg recording for more than 48 hours up to 21 days | 98 | $2,824 | $26 |
| Long return visit (40+ min) | 22 | $2,793 | $127 |
| Repair of left upper heart chamber with implant with review by radiologist | 15 | $2,641 | $176 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 98 | $2,532 | $24 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 96 | $2,523 | $23 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,840 | $167 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 11 | $1,158 | $46 |
| Programming of single lead pacemaker system | 14 | $1,138 | $46 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 22 | $1,087 | $22 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 95 | $1,054 | $10 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $1,043 | $55 |
| 3d radiographic procedure | 44 | $1,012 | $23 |
| Short return visit (20+ min) | 13 | $636 | $45 |
| Evaluation of cardiac rhythm monitor system | 13 | $598 | $33 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 11 | $578 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $509 | $27 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 48 | $370 | $6 |
2016: 35 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 141 | $101,469 | $695 |
| Return visit (30+ min) | 321 | $40,337 | $87 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 131 | $35,896 | $262 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 19 | $29,080 | $1,454 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 100 | $23,795 | $224 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 38 | $13,366 | $343 |
| Programming of heart rhythm stimulation after drug infusion | 83 | $11,271 | $131 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 124 | $11,267 | $87 |
| New patient visit (60+ min) | 62 | $10,997 | $177 |
| Short return visit (20+ min) | 149 | $10,810 | $64 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 19 | $9,060 | $227 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 336 | $7,623 | $16 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 20 | $7,225 | $344 |
| External shock to heart to regulate heart beat | 58 | $6,775 | $109 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 22 | $5,959 | $271 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $5,084 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,596 | $177 |
| Programming of dual lead pacemaker system | 50 | $4,337 | $53 |
| 3d radiographic procedure with computerized image postprocessing | 53 | $3,599 | $68 |
| Injection, regadenoson, 0.1 mg | 20 | $3,383 | None |
| New patient visit (45+ min) | 21 | $3,143 | $150 |
| External ekg recording for more than 48 hours up to 21 days | 107 | $3,120 | $26 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 107 | $2,841 | $23 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 102 | $2,696 | $22 |
| Programming of dual lead implantable defibrillator system | 16 | $1,807 | $72 |
| New patient visit (30+ min) | 16 | $1,589 | $99 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 20 | $1,461 | $70 |
| 3d radiographic procedure | 54 | $1,254 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 22 | $1,197 | $54 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 102 | $1,154 | $9 |
| Programming of single lead pacemaker system | 14 | $1,104 | $44 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 20 | $901 | $26 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 22 | $585 | $27 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 53 | $505 | $6 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 12 | $479 | $28 |
2015: 33 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 132 | $90,018 | $667 |
| Return visit (30+ min) | 333 | $52,541 | $98 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 121 | $32,049 | $261 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 71 | $27,770 | $380 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 71 | $17,593 | $241 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 37 | $13,802 | $354 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | 52 | $12,643 | $211 |
| Programming of heart rhythm stimulation after drug infusion | 81 | $11,859 | $143 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 116 | $11,774 | $99 |
| New patient visit (60+ min) | 59 | $11,643 | $197 |
| External shock to heart to regulate heart beat | 67 | $8,776 | $117 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 319 | $7,751 | $17 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $6,353 | $98 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 19 | $5,526 | $291 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $5,322 | $190 |
| Programming of dual lead pacemaker system | 50 | $5,141 | $56 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 32 | $3,820 | $116 |
| Long return visit (40+ min) | 25 | $3,717 | $143 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,973 | $68 |
| External ekg recording for more than 48 hours up to 21 days | 54 | $1,683 | $30 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 57 | $1,574 | $24 |
| Programming of dual lead implantable defibrillator system | 13 | $1,554 | $78 |
| 3d radiographic procedure | 62 | $1,462 | $24 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 54 | $1,445 | $25 |
| Short return visit (20+ min) | 19 | $1,235 | $54 |
| 3d radiographic procedure with computerized image postprocessing | 18 | $1,137 | $63 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $1,110 | $58 |
| Programming of single lead pacemaker system | 12 | $989 | $49 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 89 | $867 | $7 |
| Return visit (30+ min) | 11 | $810 | $74 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 12 | $790 | $28 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 57 | $672 | $10 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $546 | $29 |
2014: 34 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 136 | $101,489 | $715 |
| Return visit (30+ min) | 352 | $51,907 | $91 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | 132 | $37,697 | $207 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 98 | $35,129 | $338 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 87 | $32,734 | $356 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 22 | $32,575 | $1,481 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 91 | $21,788 | $229 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 46 | $18,115 | $362 |
| Programming of heart rhythm stimulation after drug infusion | 95 | $13,761 | $138 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 17 | $12,852 | $714 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 108 | $12,852 | $113 |
| New patient visit (60+ min) | 67 | $11,991 | $179 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 22 | $10,069 | $229 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 378 | $9,392 | $15 |
| External shock to heart to regulate heart beat | 70 | $8,988 | $110 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 26 | $7,375 | $284 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 27 | $6,816 | $243 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $6,105 | $93 |
| 3d radiographic procedure with computerized image postprocessing | 64 | $5,516 | $82 |
| Programming of dual lead pacemaker system | 51 | $4,668 | $54 |
| Injection, regadenoson, 0.1 mg | 22 | $3,653 | None |
| New patient visit (45+ min) | 20 | $2,947 | $147 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,880 | $180 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 22 | $1,460 | $66 |
| Ultrasound of heart blood flow, valves and chambers | 26 | $1,430 | $55 |
| Short return visit (20+ min) | 23 | $1,424 | $55 |
| Programming of dual lead implantable defibrillator system | 11 | $1,222 | $76 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,154 | $64 |
| Programming of single lead pacemaker system | 12 | $990 | $47 |
| Return visit (30+ min) | 11 | $770 | $70 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 26 | $699 | $27 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 17 | $421 | $23 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 42 | $390 | $6 |
| 3d radiographic procedure | 13 | $376 | $29 |
2013: 30 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 116 | $95,865 | $786 |
| Return visit (30+ min) | 322 | $51,257 | $92 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | 140 | $45,029 | $220 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 33 | $40,816 | $1,200 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 71 | $26,549 | $340 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 74 | $24,443 | $313 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 24 | $21,209 | $786 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 99 | $19,187 | $186 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 41 | $15,583 | $346 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 33 | $15,182 | $230 |
| New patient visit (60+ min) | 75 | $13,543 | $181 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 101 | $11,910 | $110 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 362 | $10,880 | $17 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 63 | $10,460 | $90 |
| External shock to heart to regulate heart beat | 85 | $10,235 | $106 |
| Programming of heart rhythm stimulation after drug infusion | 71 | $9,547 | $127 |
| 3d radiographic procedure with computerized image postprocessing | 71 | $5,978 | $81 |
| Injection, regadenoson, 0.1 mg | 33 | $5,613 | None |
| Programming of dual lead pacemaker system | 50 | $4,767 | $52 |
| Short return visit (20+ min) | 62 | $4,295 | $65 |
| New patient visit (45+ min) | 26 | $3,795 | $146 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 16 | $3,624 | $226 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 12 | $3,069 | $236 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,809 | $176 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 34 | $2,520 | $72 |
| Programming of dual lead implantable defibrillator system | 11 | $1,254 | $74 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $698 | $44 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 47 | $579 | $6 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 24 | $569 | $21 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $327 | $20 |
Medicaid work
$252 in 2024
Medicaid paid $252 for 12 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 12 | $252 |
| 2024 | 12 | 1 | 12 | $252 |
| 2023 | 28 | 1 | 15 | $365 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 28 | $365 |
Drugs they prescribed that Part D paid
$592,632
Pharmacies billed $592,632 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,628) in 2024. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 0%.
1,180 generic and 448 brand-name prescriptions · $592,632 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 297 | $338,543 | $1,140 |
| Xarelto | 74 | $98,901 | $1,336 |
| Dofetilide | 82 | $57,647 | $703 |
| Entresto | 18 | $22,458 | $1,248 |
| Diltiazem 24hr Er (Cd) | 118 | $7,666 | $65 |
See all 26 drugs
| Eliquis | 297 | $338,543 | $1,140 |
| Xarelto | 74 | $98,901 | $1,336 |
| Dofetilide | 82 | $57,647 | $703 |
| Entresto | 18 | $22,458 | $1,248 |
| Diltiazem 24hr Er (Cd) | 118 | $7,666 | $65 |
| Metoprolol | 152 | $2,892 | $19 |
| Propafenone Hcl Er | 21 | $2,709 | $129 |
| Flecainide Acetate | 43 | $1,670 | $39 |
| Valsartan | 39 | $1,306 | $33 |
| Digoxin | 55 | $1,159 | $21 |
| Atorvastatin | 67 | $864 | $13 |
| Potassium Chloride | 26 | $716 | $28 |
| Spironolactone | 49 | $661 | $13 |
| Sotalol | 23 | $648 | $28 |
| Clopidogrel | 45 | $632 | $14 |
| Amlodipine Besylate | 76 | $624 | $8 |
| Diltiazem 24hr Er | 11 | $571 | $52 |
| Sotalol Af | 28 | $549 | $20 |
| Amiodarone | 18 | $494 | $27 |
| Furosemide | 72 | $459 | $6 |
| Warfarin | 22 | $442 | $20 |
| Losartan | 32 | $218 | $7 |
| Metoprolol | 24 | $211 | $9 |
| Lisinopril | 11 | $122 | $11 |
| Carvedilol | 40 | $122 | $3 |
| Rosuvastatin | 18 | $116 | $6 |
Year by year
| 2024 | 1,628 | 255 | 0% (0) | 28% | $592,632 |
| 2023 | 1,543 | 231 | 0% (0) | 26% | $580,894 |
| 2022 | 1,622 | 220 | 0% (0) | None | $552,291 |
| 2021 | 1,721 | 232 | 0% (0) | 28% | $548,698 |
| 2020 | 1,615 | 218 | 0% (0) | 31% | $510,811 |
| 2019 | 1,567 | 225 | 0% (0) | 32% | $464,407 |
| 2018 | 1,500 | 211 | 0% (0) | 31% | $444,051 |
| 2017 | 1,527 | 224 | 0% (0) | 36% | $393,520 |
| 2016 | 1,474 | 212 | None | 38% | $355,689 |
| 2015 | 1,536 | 183 | 0% (0) | 41% | $320,364 |
| 2014 | 1,653 | 195 | None | 46% | $317,748 |
| 2013 | 1,569 | 201 | None | 44% | $275,707 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 25 drugs
| Eliquis | 249 | $300,203 | $1,206 |
| Xarelto | 85 | $113,816 | $1,339 |
| Dofetilide | 108 | $82,734 | $766 |
| Entresto | 12 | $14,581 | $1,215 |
| Diltiazem 24hr Er (Cd) | 97 | $9,055 | $93 |
| Repatha Sureclick | 12 | $8,050 | $671 |
| Metoprolol | 156 | $3,362 | $22 |
| Flecainide Acetate | 49 | $2,552 | $52 |
| Digoxin | 60 | $1,738 | $29 |
| Atorvastatin | 75 | $1,394 | $19 |
| Propafenone | 12 | $792 | $66 |
| Valsartan | 18 | $785 | $44 |
| Clopidogrel | 51 | $759 | $15 |
| Amiodarone | 26 | $740 | $28 |
| Sotalol Af | 20 | $678 | $34 |
| Sotalol | 18 | $646 | $36 |
| Warfarin | 29 | $549 | $19 |
| Potassium Chloride | 23 | $501 | $22 |
| Amlodipine Besylate | 58 | $479 | $8 |
| Spironolactone | 40 | $332 | $8 |
| Losartan | 37 | $317 | $9 |
| Furosemide | 52 | $266 | $5 |
| Carvedilol | 44 | $224 | $5 |
| Lisinopril | 14 | $202 | $14 |
| Metoprolol | 19 | $105 | $6 |
2022: 27 drugs
| Eliquis | 229 | $231,890 | $1,013 |
| Xarelto | 126 | $155,314 | $1,233 |
| Dofetilide | 103 | $90,093 | $875 |
| Diltiazem 24hr Er (Cd) | 117 | $7,287 | $62 |
| Repatha Sureclick | 12 | $6,523 | $544 |
| Propafenone Hcl Er | 12 | $4,698 | $391 |
| Flecainide Acetate | 61 | $3,909 | $64 |
| Metoprolol | 141 | $3,026 | $21 |
| Digoxin | 79 | $2,342 | $30 |
| Propafenone | 15 | $1,565 | $104 |
| Atorvastatin | 87 | $1,537 | $18 |
| Amiodarone | 21 | $1,150 | $55 |
| Valsartan | 23 | $1,002 | $44 |
| Clopidogrel | 41 | $789 | $19 |
| Warfarin | 34 | $725 | $21 |
| Diltiazem 24hr Er | 16 | $712 | $44 |
| Carvedilol | 58 | $663 | $11 |
| Spironolactone | 47 | $638 | $14 |
| Potassium Chloride | 21 | $601 | $29 |
| Sotalol | 17 | $553 | $33 |
| Sotalol Af | 20 | $551 | $28 |
| Amlodipine Besylate | 46 | $386 | $8 |
| Losartan | 40 | $376 | $9 |
| Furosemide | 56 | $351 | $6 |
| Metoprolol | 30 | $167 | $6 |
| Atenolol | 15 | $147 | $10 |
| Simvastatin | 17 | $65 | $4 |
2021: 27 drugs
| Eliquis | 285 | $238,044 | $835 |
| Xarelto | 129 | $137,845 | $1,069 |
| Dofetilide | 92 | $80,940 | $880 |
| Pradaxa | 18 | $24,542 | $1,363 |
| Diltiazem 24hr Er (Cd) | 119 | $9,977 | $84 |
| Propafenone Hcl Er | 22 | $8,878 | $404 |
| Flecainide Acetate | 78 | $6,619 | $85 |
| Metoprolol | 138 | $2,692 | $20 |
| Digoxin | 54 | $2,441 | $45 |
| Atorvastatin | 100 | $2,227 | $22 |
| Propafenone | 14 | $1,711 | $122 |
| Amiodarone | 15 | $978 | $65 |
| Valsartan | 30 | $949 | $32 |
| Carvedilol | 52 | $860 | $17 |
| Warfarin | 32 | $759 | $24 |
| Sotalol | 29 | $727 | $25 |
| Losartan | 38 | $667 | $18 |
| Potassium Chloride | 25 | $530 | $21 |
| Spironolactone | 49 | $519 | $11 |
| Amlodipine Besylate | 68 | $443 | $7 |
| Clopidogrel | 16 | $420 | $26 |
| Lisinopril | 14 | $378 | $27 |
| Sotalol Af | 17 | $373 | $22 |
| Rosuvastatin | 11 | $336 | $31 |
| Furosemide | 63 | $318 | $5 |
| Metoprolol | 44 | $246 | $6 |
| Simvastatin | 17 | $58 | $3 |
2020: 29 drugs
| Eliquis | 284 | $221,592 | $780 |
| Xarelto | 114 | $111,997 | $982 |
| Dofetilide | 87 | $73,883 | $849 |
| Pradaxa | 17 | $21,467 | $1,263 |
| Praluent | 13 | $17,009 | $1,308 |
| Propafenone Hcl Er | 27 | $16,267 | $602 |
| Diltiazem 24hr Er (Cd) | 104 | $10,983 | $106 |
| Flecainide Acetate | 63 | $6,729 | $107 |
| Metoprolol | 124 | $2,926 | $24 |
| Digoxin | 43 | $2,317 | $54 |
| Propafenone | 13 | $1,893 | $146 |
| Atorvastatin | 106 | $1,563 | $15 |
| Amiodarone | 27 | $1,512 | $56 |
| Valsartan | 31 | $1,454 | $47 |
| Sotalol | 36 | $1,068 | $30 |
| Cartia Xt | 21 | $994 | $47 |
| Diltiazem 24hr Er | 13 | $877 | $67 |
| Potassium Chloride | 24 | $748 | $31 |
| Warfarin | 28 | $696 | $25 |
| Carvedilol | 43 | $652 | $15 |
| Spironolactone | 36 | $583 | $16 |
| Clopidogrel | 16 | $559 | $35 |
| Losartan | 40 | $542 | $14 |
| Amlodipine Besylate | 56 | $368 | $7 |
| Furosemide | 48 | $333 | $7 |
| Lisinopril | 26 | $330 | $13 |
| Metoprolol | 19 | $262 | $14 |
| Verapamil Er | 13 | $159 | $12 |
| Simvastatin | 14 | $68 | $5 |
2019: 30 drugs
| Eliquis | 205 | $163,757 | $799 |
| Xarelto | 127 | $110,311 | $869 |
| Dofetilide | 110 | $94,884 | $863 |
| Pradaxa | 25 | $24,127 | $965 |
| Diltiazem 24hr Er (Cd) | 110 | $12,384 | $113 |
| Propafenone Hcl Er | 19 | $11,224 | $591 |
| Flecainide Acetate | 87 | $5,534 | $64 |
| Metoprolol | 122 | $2,999 | $25 |
| Propafenone | 15 | $2,282 | $152 |
| Bystolic | 11 | $1,723 | $157 |
| Digoxin | 30 | $1,462 | $49 |
| Warfarin | 60 | $1,173 | $20 |
| Cartia Xt | 18 | $1,167 | $65 |
| Atorvastatin | 64 | $1,115 | $17 |
| Diltiazem 24hr Er | 12 | $956 | $80 |
| Valsartan | 16 | $811 | $51 |
| Sotalol | 31 | $782 | $25 |
| Dilt-Xr | 17 | $699 | $41 |
| Potassium Chloride | 25 | $625 | $25 |
| Carvedilol | 44 | $608 | $14 |
| Amlodipine Besylate | 65 | $514 | $8 |
| Amiodarone | 21 | $456 | $22 |
| Clopidogrel | 13 | $365 | $28 |
| Losartan | 27 | $359 | $13 |
| Furosemide | 55 | $313 | $6 |
| Spironolactone | 29 | $305 | $11 |
| Metoprolol | 23 | $304 | $13 |
| Verapamil Er | 11 | $229 | $21 |
| Atenolol | 14 | $155 | $11 |
| Hydrochlorothiazide | 11 | $46 | $4 |
2018: 30 drugs
| Dofetilide | 151 | $144,127 | $954 |
| Xarelto | 155 | $119,545 | $771 |
| Eliquis | 114 | $91,282 | $801 |
| Pradaxa | 30 | $25,955 | $865 |
| Propafenone Hcl Er | 25 | $10,208 | $408 |
| Flecainide Acetate | 68 | $5,015 | $74 |
| Diltiazem 24hr Er (Cd) | 56 | $4,984 | $89 |
| Metoprolol | 78 | $3,030 | $39 |
| Midodrine | 12 | $2,395 | $200 |
| Propafenone | 12 | $2,391 | $199 |
| Valsartan | 24 | $1,361 | $57 |
| Atorvastatin | 73 | $1,357 | $19 |
| Cartia Xt | 35 | $1,222 | $35 |
| Warfarin | 50 | $1,155 | $23 |
| Digoxin | 16 | $1,130 | $71 |
| Digox | 13 | $1,051 | $81 |
| Amiodarone | 29 | $1,022 | $35 |
| Diltiazem 24hr Er | 17 | $958 | $56 |
| Sotalol | 29 | $793 | $27 |
| Carvedilol | 46 | $562 | $12 |
| Spironolactone | 38 | $519 | $14 |
| Losartan | 28 | $517 | $18 |
| Potassium Chloride | 21 | $445 | $21 |
| Amlodipine Besylate | 70 | $433 | $6 |
| Clopidogrel | 31 | $429 | $14 |
| Valsartan-Hydrochlorothiazide | 11 | $389 | $35 |
| Dilt-Xr | 14 | $383 | $27 |
| Furosemide | 65 | $204 | $3 |
| Metoprolol | 20 | $148 | $7 |
| Lisinopril | 12 | $91 | $8 |
2017: 30 drugs
| Dofetilide | 112 | $103,653 | $925 |
| Xarelto | 169 | $101,560 | $601 |
| Eliquis | 112 | $69,431 | $620 |
| Pradaxa | 40 | $25,793 | $645 |
| Propafenone Hcl Er | 44 | $25,260 | $574 |
| Diltiazem 24hr Er | 82 | $7,052 | $86 |
| Metoprolol | 93 | $3,954 | $43 |
| Flecainide Acetate | 50 | $2,826 | $57 |
| Midodrine | 12 | $2,190 | $182 |
| Digox | 40 | $2,144 | $54 |
| Atorvastatin | 72 | $1,745 | $24 |
| Valsartan | 31 | $1,618 | $52 |
| Digoxin | 41 | $1,596 | $39 |
| Sotalol | 55 | $1,571 | $29 |
| Amiodarone | 23 | $1,461 | $64 |
| Warfarin | 38 | $878 | $23 |
| Propafenone | 11 | $731 | $66 |
| Pravastatin | 11 | $679 | $62 |
| Cartia Xt | 16 | $590 | $37 |
| Spironolactone | 48 | $527 | $11 |
| Carvedilol | 52 | $464 | $9 |
| Potassium Chloride | 11 | $411 | $37 |
| Amlodipine Besylate | 50 | $279 | $6 |
| Furosemide | 59 | $250 | $4 |
| Clopidogrel | 19 | $201 | $11 |
| Lisinopril | 11 | $73 | $7 |
| Losartan | 11 | $72 | $7 |
| Metoprolol | 19 | $68 | $4 |
| Simvastatin | 13 | $65 | $5 |
| Atenolol | 11 | $56 | $5 |
2016: 32 drugs
| Tikosyn | 83 | $88,545 | $1,067 |
| Xarelto | 134 | $76,218 | $569 |
| Eliquis | 94 | $47,237 | $503 |
| Dofetilide | 34 | $35,746 | $1,051 |
| Propafenone Hcl Er | 52 | $24,365 | $469 |
| Pradaxa | 33 | $21,477 | $651 |
| Diltiazem 24hr Er | 46 | $5,167 | $112 |
| Metoprolol | 115 | $3,628 | $32 |
| Atorvastatin | 74 | $1,977 | $27 |
| Cartia Xt | 43 | $1,877 | $44 |
| Flecainide Acetate | 40 | $1,466 | $37 |
| Sotalol | 73 | $1,163 | $16 |
| Digox | 28 | $1,082 | $39 |
| Digoxin | 34 | $1,025 | $30 |
| Diltiazem Er | 21 | $731 | $35 |
| Valsartan | 24 | $703 | $29 |
| Warfarin | 34 | $665 | $20 |
| Carvedilol | 52 | $640 | $12 |
| Amiodarone | 18 | $422 | $23 |
| Losartan | 25 | $411 | $16 |
| Potassium Chloride | 12 | $400 | $33 |
| Sotalol Af | 14 | $381 | $27 |
| Clopidogrel | 24 | $368 | $15 |
| Amlodipine Besylate | 45 | $366 | $8 |
| Pravastatin | 12 | $342 | $28 |
| Spironolactone | 23 | $220 | $10 |
| Furosemide | 53 | $220 | $4 |
| Simvastatin | 19 | $136 | $7 |
| Levothyroxine | 12 | $126 | $11 |
| Lisinopril | 25 | $113 | $5 |
| Metoprolol | 23 | $89 | $4 |
| Atenolol | 13 | $87 | $7 |
2015: 32 drugs
| Tikosyn | 147 | $112,558 | $766 |
| Xarelto | 152 | $70,232 | $462 |
| Eliquis | 63 | $28,865 | $458 |
| Propafenone Hcl Er | 47 | $22,319 | $475 |
| Pradaxa | 28 | $16,565 | $592 |
| Multaq | 17 | $9,930 | $584 |
| Rythmol Sr | 12 | $8,065 | $672 |
| Crestor | 14 | $6,476 | $463 |
| Metoprolol | 119 | $3,867 | $32 |
| Atorvastatin | 79 | $1,946 | $25 |
| Diltiazem 24hr Er | 29 | $1,896 | $65 |
| Valsartan | 24 | $1,698 | $71 |
| Cartia Xt | 19 | $1,389 | $73 |
| Flecainide Acetate | 23 | $1,160 | $50 |
| Digox | 23 | $1,113 | $48 |
| Digitek | 17 | $1,078 | $63 |
| Warfarin | 49 | $958 | $20 |
| Digoxin | 32 | $843 | $26 |
| Sotalol | 67 | $822 | $12 |
| Carvedilol | 79 | $656 | $8 |
| Amlodipine Besylate | 80 | $599 | $7 |
| Sotalol Af | 24 | $451 | $19 |
| Losartan | 27 | $421 | $16 |
| Clopidogrel | 18 | $311 | $17 |
| Spironolactone | 32 | $287 | $9 |
| Levothyroxine | 15 | $199 | $13 |
| Furosemide | 46 | $186 | $4 |
| Simvastatin | 27 | $168 | $6 |
| Metoprolol | 25 | $156 | $6 |
| Omeprazole | 12 | $133 | $11 |
| Lisinopril | 18 | $133 | $7 |
| Atenolol | 19 | $115 | $6 |
2014: 31 drugs
| Tikosyn | 191 | $111,161 | $582 |
| Xarelto | 222 | $82,069 | $370 |
| Pradaxa | 61 | $26,910 | $441 |
| Eliquis | 62 | $19,238 | $310 |
| Propafenone Hcl Er | 31 | $14,753 | $476 |
| Diovan | 29 | $8,239 | $284 |
| Crestor | 16 | $5,606 | $350 |
| Multaq | 11 | $4,472 | $407 |
| Metoprolol | 109 | $3,648 | $33 |
| Diltiazem 24hr Er | 51 | $2,138 | $42 |
| Digox | 50 | $1,809 | $36 |
| Flecainide Acetate | 28 | $1,764 | $63 |
| Sotalol | 82 | $1,734 | $21 |
| Atorvastatin | 74 | $1,647 | $22 |
| Digoxin | 47 | $1,408 | $30 |
| Valsartan-Hydrochlorothiazide | 13 | $1,305 | $100 |
| Diltiazem Er | 27 | $926 | $34 |
| Propafenone | 11 | $782 | $71 |
| Warfarin | 45 | $657 | $15 |
| Amlodipine Besylate | 49 | $570 | $12 |
| Spironolactone | 52 | $486 | $9 |
| Carvedilol | 25 | $360 | $14 |
| Potassium Chloride | 13 | $331 | $25 |
| Omeprazole | 22 | $313 | $14 |
| Amiodarone | 18 | $312 | $17 |
| Lisinopril | 31 | $301 | $10 |
| Simvastatin | 34 | $273 | $8 |
| Clopidogrel | 15 | $258 | $17 |
| Losartan-Hydrochlorothiazide | 14 | $174 | $12 |
| Furosemide | 44 | $164 | $4 |
| Atenolol | 16 | $98 | $6 |
2013: 31 drugs
| Tikosyn | 178 | $92,037 | $517 |
| Xarelto | 165 | $55,251 | $335 |
| Pradaxa | 112 | $38,680 | $345 |
| Diovan | 42 | $11,243 | $268 |
| Propafenone | 29 | $10,551 | $364 |
| Multaq | 21 | $7,187 | $342 |
| Eliquis | 24 | $6,983 | $291 |
| Rythmol Sr | 11 | $5,303 | $482 |
| Atorvastatin | 62 | $2,770 | $45 |
| Metoprolol | 64 | $2,681 | $42 |
| Valsartan-Hydrochlorothiazide | 11 | $2,473 | $225 |
| Diltiazem 24hr Er | 43 | $1,876 | $44 |
| Potassium Chloride | 34 | $1,263 | $37 |
| Sotalol | 53 | $1,220 | $23 |
| Flecainide Acetate | 42 | $1,205 | $29 |
| Warfarin | 46 | $1,163 | $25 |
| Clopidogrel | 21 | $1,145 | $55 |
| Diltiazem Er | 15 | $797 | $53 |
| Spironolactone | 80 | $761 | $10 |
| Carvedilol | 39 | $737 | $19 |
| Amlodipine Besylate | 60 | $649 | $11 |
| Amiodarone | 22 | $560 | $25 |
| Simvastatin | 38 | $517 | $14 |
| Digox | 55 | $449 | $8 |
| Lisinopril | 44 | $435 | $10 |
| Furosemide | 62 | $367 | $6 |
| Losartan-Hydrochlorothiazide | 21 | $305 | $15 |
| Omeprazole | 16 | $275 | $17 |
| Torsemide | 13 | $252 | $19 |
| Levothyroxine | 11 | $191 | $17 |
| Atenolol | 16 | $39 | $2 |
Money from drug and device companies
$1,685 in 2025
| 2025 | 6 | 23 | None | $1,685 |
| 2024 | 5 | 33 | None | $1,568 |
| 2023 | 5 | 20 | None | $1,438 |
| 2022 | 6 | 7 | $700 | $1,354 |
| 2021 | 3 | 3 | None | $406 |
| 2020 | 3 | 4 | None | $191 |
| 2019 | 14 | 64 | None | $1,209 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AtriCure | Epi-Sense Guided Coagulation System With Visitrax | $702 | 8 payments
|
| Abbott Laboratories | Ensite | $318 | 5 payments
|
| Biosense Webster | Carto 3 | $266 | 7 payments
|
| Medtronic | Aurora Ev-Icd Mri Surescan | $164 | 1 payment
|
| Boston Scientific | Farapulse | $137 | 1 payment
|
| W. L. Gore & Associates | Excluder Conformable Aaa Endoprosthesis With Active Control | $98 | 1 payment
|
See all 23 published payments
| W. L. Gore & Associates | Meals · 2025-12-02 | Excluder Conformable Aaa Endoprosthesis With Active Control | $98 |
| Biosense Webster | Meals · 2025-10-28 | Soundstar | $29 |
| AtriCure | Meals · 2025-09-18 | Synergy Ablation System | $186 |
| AtriCure | Meals · 2025-08-18 | Atriclip Laa Exclusion System | $27 |
| Biosense Webster | Meals · 2025-08-13 | Nuvision Ice Catheter | $26 |
| Biosense Webster | Meals · 2025-07-30 | Carto 3 | $144 |
| AtriCure | Meals · 2025-07-23 | Epi-Sense Guided Coagulation System With Visitrax | $164 |
| AtriCure | Meals · 2025-07-17 | Epi-Sense Guided Coagulation System With Visitrax | $37 |
| Abbott Laboratories | Meals · 2025-07-11 | Perclose Prostyle | $31 |
| Abbott Laboratories | Meals · 2025-06-27 | Agilis | $25 |
| Biosense Webster | Meals · 2025-05-30 | Carto 3 | $5 |
| AtriCure | Meals · 2025-05-27 | Epi-Sense Guided Coagulation System With Visitrax | $106 |
| Medtronic | Meals · 2025-05-19 | Aurora Ev-Icd Mri Surescan | $164 |
| AtriCure | Meals · 2025-05-19 | Synergy Ablation System | $36 |
| AtriCure | Meals · 2025-05-19 | Synergy Ablation System | $11 |
| Abbott Laboratories | Meals · 2025-05-01 | Agilis | $24 |
| Boston Scientific | Meals · 2025-04-16 | Farapulse | $137 |
| Biosense Webster | Meals · 2025-04-05 | Nuvision Ice Catheter | $26 |
| Biosense Webster | Meals · 2025-03-29 | Carto 3 | $4 |
| Biosense Webster | Meals · 2025-03-27 | Carto 3 | $32 |
| AtriCure | Meals · 2025-03-20 | Epi-Sense Guided Coagulation System With Visitrax | $136 |
| Abbott Laboratories | Meals · 2025-03-17 | Ensite | $214 |
| Abbott Laboratories | Meals · 2025-03-11 | Perclose Prostyle | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,568
| Boston Scientific | Rhythmia Mapping System | $617 | 12 payments
|
| Biosense Webster | Carto 3 | $593 | 18 payments
|
| Impulse Dynamics (USA) | Optimizer | $185 | 1 payment
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $149 | 1 payment
|
| Abbott Laboratories | Workmate Claris | $23 | 1 payment
|
2023: $1,438
| Biosense Webster | Carto 3 | $543 | 13 payments
|
| Abbott Laboratories | Ensite | $363 | 2 payments
|
| Ablacon | None | $241 | 1 payment
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $150 | 1 payment
|
| Medtronic | Micra | $140 | 3 payments
|
2022: $1,354
| Medical Device Business Services | Carto 3 | $700 | 1 payment
|
| Abbott Laboratories | Ensite Precision | $212 | 1 payment
|
| Boston Scientific | Watchman Access System | $168 | 2 payments
|
| Medtronic | None | $130 | 1 payment
|
| Biosense Webster | Carto 3 | $109 | 1 payment
|
| AtriCure | Synergy Ablation System | $35 | 1 payment
|
2021: $406
| Abbott Laboratories | Ensite Precision Cardiac Mapping System | $170 | 1 payment
|
| Biosense Webster | Carto 3 | $121 | 1 payment
|
| Boston Scientific | Choice | $115 | 1 payment
|
2020: $191
| Biosense Webster | Carto 3 System | $132 | 1 payment
|
| Pfizer | Eliquis | $43 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $16 | 1 payment
|
2019: $1,209
| Pfizer | Vyndaqel | $197 | 20 payments
|
| Amgen | Repatha | $188 | 7 payments
|
| Janssen Pharmaceuticals | Xarelto | $138 | 9 payments
|
| Medtronic Vascular | 3f | $113 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $103 | 5 payments
|
| Sanofi-Aventis U.S. | Multaq | $97 | 5 payments
|
| Novartis Pharmaceuticals | Entresto | $89 | 4 payments
|
| Biosense Webster | Carto 3 System | $68 | 1 payment
|
| Boston Scientific | Watchman | $61 | 4 payments
|
| Daiichi Sankyo | Injectafer | $35 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Pradaxa | $35 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $35 | 2 payments
|
| Biotronik | None | $25 | 1 payment
|
| Abbott Laboratories | Mitra Clip System | $25 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Abbott Laboratories · Multi-Center Acute Safety Trial of Tacticath Contact Force Ablation Catheter, Sensor Enabled (Tacticath Se) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation · 2020 | Their institution | $5,750 |
| Abbott Laboratories · Multi-Center Acute Safety Trial of Tacticath Contact Force Ablation Catheter, Sensor Enabled (Tacticath Se) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation · 2019 | Their institution | $5,653 |
| Abbott Laboratories · Safety and Effectiveness Trial for the Nanostim Leadless Pacemaker · 2020 | Their institution | $1,650 |
| Abbott Laboratories · A Safety and Effectiveness Trial for A Leadless Pacemaker System · 2019 | Their institution | $1,325 |
| Abbott Laboratories · Safety and Effectiveness Trial for the Nanostim Leadless Pacemaker · 2022 | Their institution | $1,075 |
| Abbott Laboratories · A Safety and Effectiveness Trial for A Leadless Pacemaker System · 2021 | Their institution | $1,025 |
Professional record
- NPI
- 1912932914
- Licence
- CA A54594California A54594: Current · expires 2026-11-30
- Trained
- University of California, Geffen School of Medicine, 1994
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Cardiology (207RC0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-07-11
- NPI last updated
- 2020-05-28
- NPI record certified
- 2020-05-28
This is when the NPI record was last certified, not a medical board exam.